(Q51394480)

4 April 2018

title

Fluoxetine decreases concentrations of 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression. (English)

1 reference

4 April 2018

1 reference

Ströhle A

1

1 reference

4 April 2018

Pasini A

2

1 reference

4 April 2018

Romeo E

3

1 reference

4 April 2018

Hermann B

4

1 reference

4 April 2018

Spalletta G

5

1 reference

4 April 2018

di Michele F

6

1 reference

4 April 2018

Holsboer F

7

1 reference

4 April 2018

Rupprecht R

8

1 reference

4 April 2018

publication date

1 May 2000

1 reference

4 April 2018

Journal of Psychiatric Research

published in

1 reference

4 April 2018

volume

34

1 reference

4 April 2018

issue

3

1 reference

4 April 2018

page(s)

183-186

1 reference

4 April 2018

Neurosteroids: 3 alpha-hydroxy-5 alpha-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900006-6

Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900006-6

Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnanolone) availability?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900006-6

Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900006-6

Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900006-6

Effects of antidepressant treatment on neuroactive steroids in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900006-6

Progesterone receptor-mediated effects of neuroactive steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900006-6

Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900006-6

Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900006-6

Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900006-6

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900006-6

10.1016/S0022-3956(00)00006-6

7 January 2021

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018